Expression of the glaucoma mutant E50K in RGCs revealed no difference in interferon regulatory transcription factor 3 (IRF3) activation compared to cells expressing wild-type optineurin (131), suggesting that this pathway may not be implicated in glaucoma. This evidence concerns the gene OPTN and glaucoma.